Tempest Therapeutics, Inc. TPST 深 沪
已收盘 08-14 16:00:00 美东时间
1.015
-0.155
-13.25%
华盛通- 最 高1.12
- 今 开1.12
- 成交量 43.52万股
- 最 低 0.9942
- 昨 收 1.17
- 总市值 1621.91万
- 52周最高 12.23
- 市盈率 静 --
- 换手率 2.72%
- 52周最低 0.8401
- 委 比 -11.11%
- 总股本 1597.94万
- 历史最高 3381.30
- 量 比 0.73
- 振 幅 10.75%
- 历史最低 0.8401
- 每 手 1
- 风险率 3.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tempest Therapeutics Q2 EPS $(0.34) Misses $(0.30) Estimate
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 83.57 percent increase over losses of $(2.07) per share from the same period last year.
08-14 04:42
Tempest And Senlang To Collaborate To Develop Tempest’s Proprietary TPST-4003 Product Candidate, Beginning With IIT In China Evaluating TPST-4003 In ~10 Patients With MG Or MS; Expects First Patient Enrollment And Dosing To Occur In Q4 Of 2026
Tempest’s TPST-4003 is a next-generation in vivo CAR-T candidate combining proprietary CD7-targeted mRNA/LNP delivery with a dual-target CD19/BCMA CAR construct designed to enable broad B-cell lineage depletion and immune reset for autoimmune and oncology indications Senlang Biotechnology, a clinica...
07-21 19:08
Tempest Therapeutics shares are trading lower after the company announced the exercise of warrants to buy approximately 1.2 million shares at a reduced exercise price of $1.73 per share.
Tempest Therapeutics shares are trading lower after the company announced the e...
05-30 01:09
Tempest Therapeutics Q1 Adj. EPS $(0.50) Misses $(0.28) Estimate
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.28) by 78.57 percent. This is a 84.18 percent increase over losses of $(3.16) per share
05-15 05:23
Tempest Therapeutics Reaches Milestone In TPST-2003 Manufacturing Process
TPST-2003 is an autologous CD19/BCMA dual-targeting CAR-T therapy designed to improve response depth and durability in patients with relapsed/refractory multiple myeloma ("rrMM") through a parallel dual-targeting CAR
04-22 20:10
Tempest Therapeutics Q4 EPS $(0.62) Beats $(3.52) Estimate
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(3.52) by 82.39 percent. This is a 87.77 percent increase over losses of $(5.07) per share
03-30 21:06
美股夜盘 | Tempest Therapeutics, Inc.涨36.78%，最新股价2.38美元
Tempest Therapeutics, Inc.涨36.78%，报2.38美元
03-26 15:06
美股夜盘 | Southland Holdings, Inc.涨49.24%，Tempest Therapeutics, Inc.涨36.21%
Southland Holdings, Inc.涨49.24%；Tempest Therapeutics, Inc.涨36.21%；Rani Therapeutics涨22.81%
03-26 15:01
美股夜盘 | Southland Holdings, Inc.涨53.03%，Navan, Inc. Class A涨26.45%
Southland Holdings, Inc.涨53.03%；Navan, Inc. Class A涨26.45%；Rani Therapeutics涨22.81%
03-26 13:03
美股夜盘 | Southland Holdings, Inc.涨50.76%，Navan, Inc. Class A涨27.32%
Southland Holdings, Inc.涨50.76%；Navan, Inc. Class A涨27.32%；Epsium Enterprise涨22.14%
03-26 09:04
